Internet to the Rescue
Pharmaceutical Executive
In response to concerns about the low level of patient participation in clinical trials, the British Medical Association has launched an internet resource aimed at encouraging more patients to take part. Aimed at healthcare professionals, the site explains how different types of trials are conducted and spells out their ethical and best practices requirements.
In response to concerns about the low level of patient participation in clinical trials, the British Medical Association has launched an internet resource aimed at encouraging more patients to take part. Aimed at healthcare professionals, the site explains how different types of trials are conducted and spells out their ethical and best practices requirements.
BMA's head of science and ethics, Dr. Vivienne Nathanson, warns that low patient participation can hinder medical research. She says, "The involvement and cooperation of doctors and patients is crucial to the success of a clinical trial."
The site includes several initiatives that should increase the number of trial participants, including links to online registers, where patients can find details of studies suitable for them. It also suggests to their doctors that they take part. One of the initiatives mentioned in the resource is that patients should be able to access online trial registers, so they can find out what trials are taking place. That way, they can suggest to their doctor that they would like to participate
The site also recommends that healthcare providers give internet resources for clinical trials more widespread publicity, such as in hospital waiting rooms and doctors' offices.
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
